ScholarIQanswers from OpenAlex

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

PaperCitations, authors & open-access status

Autoantibodies against type I IFNs in patients with life-threatening COVID-19 is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Autoantibodies against type I IFNs in patients with life-threatening COVID-19 have?

ScholarIQcitation count

Autoantibodies against type I IFNs in patients with life-threatening COVID-19 has 2,866 citations in the OpenAlex counts ScholarIQ stores.

When was Autoantibodies against type I IFNs in patients with life-threatening COVID-19 published?

ScholarIQyear

Autoantibodies against type I IFNs in patients with life-threatening COVID-19 has 2020 year in the ScholarIQ index.

What is the open-access status of Autoantibodies against type I IFNs in patients with life-threatening COVID-19?

ScholarIQoa status

Autoantibodies against type I IFNs in patients with life-threatening COVID-19 has hybrid oa status in the ScholarIQ index.

What is the DOI of Autoantibodies against type I IFNs in patients with life-threatening COVID-19?

ScholarIQdoi

The DOI for Autoantibodies against type I IFNs in patients with life-threatening COVID-19 is on the source record.

What is the PMID of Autoantibodies against type I IFNs in patients with life-threatening COVID-19?

ScholarIQpmid

The PMID for Autoantibodies against type I IFNs in patients with life-threatening COVID-19 is on the source record.

What is the OpenAlex record for Autoantibodies against type I IFNs in patients with life-threatening COVID-19?

ScholarIQopenalex

The OpenAlex for Autoantibodies against type I IFNs in patients with life-threatening COVID-19 is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial